Markku Kaste1. Show Affiliations » 1. Helsinki University Central Hospital, Department of Neurology, University of Helsinki, Helsinki, FI-00029 HUS, Finland. markku.kaste@hus.fi
Abstract
Entities: Disease
Mesh: See more » AnimalsClinical Trials as Topic/methodsClinical Trials as Topic/trendsFibrinolytic Agents/administration & dosageHumansStroke/drug therapyStroke/epidemiologyStroke/prevention & controlThrombolytic Therapy/methodsThrombolytic Therapy/trendsTissue Plasminogen Activator/administration & dosage
Substances: See more » Fibrinolytic AgentsTissue Plasminogen Activator
Year: 2013 PMID: 23237887 DOI: 10.1016/S1474-4422(12)70273-9
Source DB: PubMed Journal: Lancet Neurol ISSN: 1474-4422 Impact factor: 44.182